4-(5-(3,5-di-tert-butylphenyl)-1-(4-(dimethylcarbamoyl)phenyl)-1H-pyrazol-3-yl)benzoic acid

ID: ALA3814385

Chembl Id: CHEMBL3814385

PubChem CID: 89555356

Max Phase: Preclinical

Molecular Formula: C33H37N3O3

Molecular Weight: 523.68

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)C(=O)c1ccc(-n2nc(-c3ccc(C(=O)O)cc3)cc2-c2cc(C(C)(C)C)cc(C(C)(C)C)c2)cc1

Standard InChI:  InChI=1S/C33H37N3O3/c1-32(2,3)25-17-24(18-26(19-25)33(4,5)6)29-20-28(21-9-11-23(12-10-21)31(38)39)34-36(29)27-15-13-22(14-16-27)30(37)35(7)8/h9-20H,1-8H3,(H,38,39)

Standard InChI Key:  DXGJLPTZLVIFFO-UHFFFAOYSA-N

Associated Targets(Human)

RARG Tclin Retinoic acid receptor RXR-alpha/gamma (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RARB Tclin Retinoic acid receptor RXR-alpha/Retinoic acid receptor beta (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RARG Tclin Retinoic acid receptor gamma (1154 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RARA Tclin Retinoic acid receptor alpha/Retinoid X receptor alpha (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 523.68Molecular Weight (Monoisotopic): 523.2835AlogP: 7.20#Rotatable Bonds: 5
Polar Surface Area: 75.43Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.90CX Basic pKa: 1.43CX LogP: 7.71CX LogD: 4.49
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.30Np Likeness Score: -1.08

References

1. Hughes NE, Bleisch TJ, Jones SA, Richardson TI, Doti RA, Wang Y, Stout SL, Durst GL, Chambers MG, Oskins JL, Lin C, Adams LA, Page TJ, Barr RJ, Zink RW, Osborne H, Montrose-Rafizadeh C, Norman BH..  (2016)  Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design.,  26  (14): [PMID:27261179] [10.1016/j.bmcl.2016.05.056]

Source